• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXA1 通过诱导多种促血管生成因子的表达促进前列腺癌血管生成。

FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression.

机构信息

Department of Urology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, 85 Wujin Road, Shanghai, 200080, People's Republic of China.

出版信息

J Cancer Res Clin Oncol. 2021 Nov;147(11):3225-3243. doi: 10.1007/s00432-021-03730-3. Epub 2021 Jul 14.

DOI:10.1007/s00432-021-03730-3
PMID:34258652
Abstract

PURPOSE

FOXA1, as a pioneering transcription factor, has been shown to drive prostate cancer progression. Previous studies showed that FOXA1 expression in prostate cancer was positively associated with cancer angiolymphatic invasion and metastasis. However, the mechanism underlying the correlation between FOXA1 and prostate cancer angiolymphatic invasion and metastasis remains largely unclear.

METHODS

Herein, we set out to investigate the role of FOXA1 in the interactions between prostate cancer cells and endothelial cells. Endothelial cells' phenotypes were assessed through CCK-8 assay, Transwell migration assay, and tube formation assay. The angiogenic factors acting on endothelial cells mediated by FOXA1were characterized by RNA-seq, qPCR array, angiogenesis cytokines array, and ELISA assay. The impact of FOXA1 on tumor angiogenesis was examined in a xenograft model in nude mice. The effect of FOXA1 on prostate cancer angiogenesis was validated on a primary prostate cancer tissue microarray.

RESULTS

FOXA1 expression in prostate cancer cells promoted endothelial cell proliferation, migration, and tube formation in vitro. Mechanistically, FOXA1 increased pro-angiogenic factors production, including EGF, Endothelin-1, and Endoglin. Moreover, in vivo study showed that FOXA1 facilitated tumor angiogenesis. Furthermore, clinical samples investigation indicated that FOXA1 enhanced prostate cancer angiogenesis.

CONCLUSION

Overall, these findings illustrated a tumor angiogenesis-promoting role of FOXA1 in prostate cancer.

摘要

目的

FOXA1 作为一种先驱转录因子,已被证明能促进前列腺癌的进展。先前的研究表明,FOXA1 在前列腺癌中的表达与癌症的血管淋巴管浸润和转移呈正相关。然而,FOXA1 与前列腺癌血管淋巴管浸润和转移之间的相关性的机制在很大程度上仍不清楚。

方法

本研究旨在探讨 FOXA1 在前列腺癌细胞与内皮细胞相互作用中的作用。通过 CCK-8 测定、Transwell 迁移测定和管形成测定评估内皮细胞的表型。通过 RNA-seq、qPCR 阵列、血管生成细胞因子阵列和 ELISA 测定来描述 FOXA1 作用于内皮细胞的血管生成因子。在裸鼠异种移植模型中检查 FOXA1 对肿瘤血管生成的影响。在原发性前列腺癌组织微阵列上验证 FOXA1 对前列腺癌血管生成的影响。

结果

前列腺癌细胞中的 FOXA1 表达促进了内皮细胞的增殖、迁移和体外管形成。从机制上讲,FOXA1 增加了促血管生成因子的产生,包括 EGF、内皮素-1 和内格林。此外,体内研究表明 FOXA1 促进了肿瘤血管生成。此外,临床样本研究表明 FOXA1 增强了前列腺癌的血管生成。

结论

总的来说,这些发现说明了 FOXA1 在前列腺癌中具有促进肿瘤血管生成的作用。

相似文献

1
FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression.FOXA1 通过诱导多种促血管生成因子的表达促进前列腺癌血管生成。
J Cancer Res Clin Oncol. 2021 Nov;147(11):3225-3243. doi: 10.1007/s00432-021-03730-3. Epub 2021 Jul 14.
2
Ephrin-A2 promotes prostate cancer metastasis by enhancing angiogenesis and promoting EMT.Ephrin-A2通过增强血管生成和促进上皮-间质转化来促进前列腺癌转移。
J Cancer Res Clin Oncol. 2021 Jul;147(7):2013-2023. doi: 10.1007/s00432-021-03618-2. Epub 2021 Mar 27.
3
TGF-β1 facilitates gallbladder carcinoma metastasis by regulating FOXA1 translation efficiency through mA modification.TGF-β1 通过 mA 修饰调控 FOXA1 翻译效率促进胆囊癌转移。
Cell Death Dis. 2024 Jun 17;15(6):422. doi: 10.1038/s41419-024-06800-9.
4
The preventative effects of sunitinib malate observed in the course from non-castration to castration LNCaP xenograft prostate tumors.马来酸舒尼替尼在非去势到去势 LNCaP 异种移植前列腺肿瘤过程中观察到的预防作用。
J Cancer Res Clin Oncol. 2012 Dec;138(12):2137-43. doi: 10.1007/s00432-012-1295-y. Epub 2012 Aug 7.
5
FLT1-enriched extracellular vesicles induce a positive feedback loop between nasopharyngeal carcinoma cells and endothelial cells to promote angiogenesis and tumour metastasis.富含FLT1的细胞外囊泡在鼻咽癌细胞和内皮细胞之间诱导正反馈回路,以促进血管生成和肿瘤转移。
Oncogene. 2025 Apr 13. doi: 10.1038/s41388-025-03389-x.
6
Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.奥曲肽作为一种抗肿瘤血管生成化合物,可抑制携带人肝细胞癌异种移植瘤的裸鼠的肿瘤生长。
J Cancer Res Clin Oncol. 2003 Jun;129(6):327-34. doi: 10.1007/s00432-003-0447-5. Epub 2003 Jun 14.
7
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.FOXA1 的染色质结合由 LSD1 介导的去甲基化促进,发生在前列腺癌中。
Nat Genet. 2020 Oct;52(10):1011-1017. doi: 10.1038/s41588-020-0681-7. Epub 2020 Aug 31.
8
SP1-Mediated Upregulation of KIF4A Promotes Prostate Cancer Progression via Targeting TWIST1.SP1介导的KIF4A上调通过靶向TWIST1促进前列腺癌进展。
J Biochem Mol Toxicol. 2025 Jul;39(7):e70378. doi: 10.1002/jbt.70378.
9
In Vitro and In Vivo Analyses Reveal Tumor-Derived Exosome miR-558 Promotes Angiogenesis in Tongue Squamous Cell Carcinoma by Targeting Heparinase.体外和体内分析揭示肿瘤来源的外泌体 miR-558 通过靶向肝素酶促进舌鳞状细胞癌血管生成。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241261615. doi: 10.1177/15330338241261615.
10
LncRNA BDNF-AS binds to DNMT1 to suppress angiogenesis in glioma by promoting NEDD4L-mediated YAP1 ubiquitination.长链非编码RNA BDNF-AS通过促进NEDD4L介导的YAP1泛素化与DNMT1结合以抑制神经胶质瘤中的血管生成。
Mol Cell Biochem. 2025 Mar 21. doi: 10.1007/s11010-025-05250-x.

引用本文的文献

1
DCTPP1 is Transcriptionally Activated by FOXA1 to Affect Cisplatin Sensitivity in Triple-Negative Breast Cancer via Suppression of Ferroptosis.DCTPP1被FOXA1转录激活,通过抑制铁死亡影响三阴性乳腺癌对顺铂的敏感性。
Cell Biochem Biophys. 2025 Jun 23. doi: 10.1007/s12013-025-01801-7.
2
Three-dimensional regulatory hubs support oncogenic programs in glioblastoma.三维调控枢纽支持胶质母细胞瘤中的致癌程序。
Mol Cell. 2025 Apr 3;85(7):1330-1348.e6. doi: 10.1016/j.molcel.2025.03.007. Epub 2025 Mar 26.
3
Role of Chemokines and Cytokines in Prostate Cancer Skeletal Metastasis.

本文引用的文献

1
Chromatin binding of FOXA1 is promoted by LSD1-mediated demethylation in prostate cancer.FOXA1 的染色质结合由 LSD1 介导的去甲基化促进,发生在前列腺癌中。
Nat Genet. 2020 Oct;52(10):1011-1017. doi: 10.1038/s41588-020-0681-7. Epub 2020 Aug 31.
2
Advanced Prostate Cancer: Treatment Advances and Future Directions.晚期前列腺癌:治疗进展与未来方向。
Trends Cancer. 2020 Aug;6(8):702-715. doi: 10.1016/j.trecan.2020.04.010. Epub 2020 Jun 10.
3
A genomic and epigenomic atlas of prostate cancer in Asian populations.亚洲人群前列腺癌的基因组和表观基因组图谱。
趋化因子和细胞因子在前列腺癌骨转移中的作用。
Curr Osteoporos Rep. 2024 Nov 25;23(1):3. doi: 10.1007/s11914-024-00897-9.
4
Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota.前列腺癌微环境:免疫细胞、血管系统、基质细胞和微生物群的多维调控。
Mol Cancer. 2024 Oct 12;23(1):229. doi: 10.1186/s12943-024-02137-1.
5
Evaluating the predictive value of angiogenesis-related genes for prognosis and immunotherapy response in prostate adenocarcinoma using machine learning and experimental approaches.运用机器学习和实验方法评估血管生成相关基因对前列腺腺癌预后和免疫治疗反应的预测价值。
Front Immunol. 2024 May 16;15:1416914. doi: 10.3389/fimmu.2024.1416914. eCollection 2024.
6
Crosstalk between Endothelial Cells and Tumor Cells: A New Era in Prostate Cancer Progression.内皮细胞与肿瘤细胞的串扰:前列腺癌进展的新时代。
Int J Mol Sci. 2023 Nov 29;24(23):16893. doi: 10.3390/ijms242316893.
7
Targeting PI3K/Akt signaling in prostate cancer therapy.在前列腺癌治疗中靶向PI3K/Akt信号通路
J Cell Commun Signal. 2023 Sep;17(3):423-443. doi: 10.1007/s12079-022-00702-1. Epub 2022 Nov 11.
8
FOXA1 in prostate cancer.FOXA1 在前列腺癌中的作用。
Asian J Androl. 2023 May-Jun;25(3):287-295. doi: 10.4103/aja202259.
9
Comparative Pathobiology of Canine and Human Prostate Cancer: State of the Art and Future Directions.犬类和人类前列腺癌的比较病理生物学:现状与未来方向
Cancers (Basel). 2022 May 31;14(11):2727. doi: 10.3390/cancers14112727.
10
Correlation of NTRK1 Downregulation with Low Levels of Tumor-Infiltrating Immune Cells and Poor Prognosis of Prostate Cancer Revealed by Gene Network Analysis.基因网络分析揭示 NTRK1 下调与肿瘤浸润免疫细胞水平低和前列腺癌预后不良相关。
Genes (Basel). 2022 May 8;13(5):840. doi: 10.3390/genes13050840.
Nature. 2020 Apr;580(7801):93-99. doi: 10.1038/s41586-020-2135-x. Epub 2020 Mar 25.
4
Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer.非编码突变靶向前列腺癌 FOXA1 丛的顺式调控元件。
Nat Commun. 2020 Jan 23;11(1):441. doi: 10.1038/s41467-020-14318-9.
5
RNA-binding protein Musashi2 stabilizing androgen receptor drives prostate cancer progression.RNA 结合蛋白 Musashi2 稳定雄激素受体促进前列腺癌进展。
Cancer Sci. 2020 Feb;111(2):369-382. doi: 10.1111/cas.14280. Epub 2020 Jan 4.
6
Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners.内格琳蛋白相互作用组分析鉴定出 TRIM21 和半乳糖凝集素-3 为新的结合伴侣。
Cells. 2019 Sep 13;8(9):1082. doi: 10.3390/cells8091082.
7
Role of soluble endoglin in BMP9 signaling.可溶性内皮糖蛋白在 BMP9 信号通路中的作用。
Proc Natl Acad Sci U S A. 2019 Sep 3;116(36):17800-17808. doi: 10.1073/pnas.1816661116. Epub 2019 Aug 20.
8
Altered chromatin recruitment by FOXA1 mutations promotes androgen independence and prostate cancer progression.FOXA1突变导致的染色质募集改变促进雄激素非依赖性和前列腺癌进展。
Cell Res. 2019 Sep;29(9):773-775. doi: 10.1038/s41422-019-0204-1. Epub 2019 Jul 19.
9
Forkhead domain mutations in FOXA1 drive prostate cancer progression.FOXA1中的叉头结构域突变会推动前列腺癌进展。
Cell Res. 2019 Sep;29(9):770-772. doi: 10.1038/s41422-019-0203-2. Epub 2019 Jul 19.
10
Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.晚期前列腺癌中 FOXA1 激活突变的不同结构类别。
Nature. 2019 Jul;571(7765):413-418. doi: 10.1038/s41586-019-1347-4. Epub 2019 Jun 26.